201 related articles for article (PubMed ID: 20096948)
1. No association between SNPs regulating TGF-β1 secretion and late radiotherapy toxicity to the breast: results from the RAPPER study.
Barnett GC; Coles CE; Burnet NG; Pharoah PD; Wilkinson J; West CM; Elliott RM; Baynes C; Dunning AM
Radiother Oncol; 2010 Oct; 97(1):9-14. PubMed ID: 20096948
[TBL] [Abstract][Full Text] [Related]
2. Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity.
Barnett GC; Elliott RM; Alsner J; Andreassen CN; Abdelhay O; Burnet NG; Chang-Claude J; Coles CE; Gutiérrez-Enríquez S; Fuentes-Raspall MJ; Alonso-Muñoz MC; Kerns S; Raabe A; Symonds RP; Seibold P; Talbot CJ; Wenz F; Wilkinson J; Yarnold J; Dunning AM; Rosenstein BS; West CM; Bentzen SM
Radiother Oncol; 2012 Dec; 105(3):289-95. PubMed ID: 23199655
[TBL] [Abstract][Full Text] [Related]
3. Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Grossberg AJ; Lei X; Xu T; Shaitelman SF; Hoffman KE; Bloom ES; Stauder MC; Tereffe W; Schlembach PJ; Woodward WA; Buchholz TA; Smith BD
JAMA Oncol; 2018 Dec; 4(12):1751-1757. PubMed ID: 30027292
[TBL] [Abstract][Full Text] [Related]
4. SNPs in genes implicated in radiation response are associated with radiotoxicity and evoke roles as predictive and prognostic biomarkers.
Alsbeih G; El-Sebaie M; Al-Harbi N; Al-Hadyan K; Shoukri M; Al-Rajhi N
Radiat Oncol; 2013 May; 8():125. PubMed ID: 23697595
[TBL] [Abstract][Full Text] [Related]
5. Association between SNPs in defined functional pathways and risk of early or late toxicity as well as individual radiosensitivity.
Reuther S; Szymczak S; Raabe A; Borgmann K; Ziegler A; Petersen C; Dikomey E; Hoeller U
Strahlenther Onkol; 2015 Jan; 191(1):59-66. PubMed ID: 25156511
[TBL] [Abstract][Full Text] [Related]
6. Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity.
Zschenker O; Raabe A; Boeckelmann IK; Borstelmann S; Szymczak S; Wellek S; Rades D; Hoeller U; Ziegler A; Dikomey E; Borgmann K
Radiother Oncol; 2010 Oct; 97(1):26-32. PubMed ID: 20170971
[TBL] [Abstract][Full Text] [Related]
7. No association between TGFB1 polymorphisms and late radiotherapy toxicity: a meta-analysis.
Zhu ML; Wang M; Shi TY; Li QX; Xi P; Xia KQ; Zheng L; Wei QY
PLoS One; 2013; 8(10):e76964. PubMed ID: 24130819
[TBL] [Abstract][Full Text] [Related]
8. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study.
Barnett GC; Coles CE; Elliott RM; Baynes C; Luccarini C; Conroy D; Wilkinson JS; Tyrer J; Misra V; Platte R; Gulliford SL; Sydes MR; Hall E; Bentzen SM; Dearnaley DP; Burnet NG; Pharoah PD; Dunning AM; West CM
Lancet Oncol; 2012 Jan; 13(1):65-77. PubMed ID: 22169268
[TBL] [Abstract][Full Text] [Related]
9. Association of single nucleotide polymorphisms in the genes ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with risk of severe erythema after breast conserving radiotherapy.
Raabe A; Derda K; Reuther S; Szymczak S; Borgmann K; Hoeller U; Ziegler A; Petersen C; Dikomey E
Radiat Oncol; 2012 Apr; 7():65. PubMed ID: 22537351
[TBL] [Abstract][Full Text] [Related]
10. Common variants of GSTP1, GSTA1, and TGFβ1 are associated with the risk of radiation-induced fibrosis in breast cancer patients.
Terrazzino S; La Mattina P; Gambaro G; Masini L; Franco P; Canonico PL; Genazzani AA; Krengli M
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):504-11. PubMed ID: 22079734
[TBL] [Abstract][Full Text] [Related]
11. A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.
Barnett GC; Thompson D; Fachal L; Kerns S; Talbot C; Elliott RM; Dorling L; Coles CE; Dearnaley DP; Rosenstein BS; Vega A; Symonds P; Yarnold J; Baynes C; Michailidou K; Dennis J; Tyrer JP; Wilkinson JS; Gómez-Caamaño A; Tanteles GA; Platte R; Mayes R; Conroy D; Maranian M; Luccarini C; Gulliford SL; Sydes MR; Hall E; Haviland J; Misra V; Titley J; Bentzen SM; Pharoah PD; Burnet NG; Dunning AM; West CM
Radiother Oncol; 2014 May; 111(2):178-85. PubMed ID: 24785509
[TBL] [Abstract][Full Text] [Related]
12. XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients.
Seibold P; Behrens S; Schmezer P; Helmbold I; Barnett G; Coles C; Yarnold J; Talbot CJ; Imai T; Azria D; Koch CA; Dunning AM; Burnet N; Bliss JM; Symonds RP; Rattay T; Suga T; Kerns SL; Bourgier C; Vallis KA; Sautter-Bihl ML; Claßen J; Debus J; Schnabel T; Rosenstein BS; Wenz F; West CM; Popanda O; Chang-Claude J
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1084-1092. PubMed ID: 26072091
[TBL] [Abstract][Full Text] [Related]
13. TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer.
Andreassen CN; Alsner J; Overgaard J; Herskind C; Haviland J; Owen R; Homewood J; Bliss J; Yarnold J
Radiother Oncol; 2005 Apr; 75(1):18-21. PubMed ID: 15878096
[TBL] [Abstract][Full Text] [Related]
14. No effect of the transforming growth factor β1 promoter polymorphism C-509T on TGFB1 gene expression, protein secretion, or cellular radiosensitivity.
Reuther S; Metzke E; Bonin M; Petersen C; Dikomey E; Raabe A
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):460-5. PubMed ID: 22592044
[TBL] [Abstract][Full Text] [Related]
15. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes.
Andreassen CN; Alsner J; Overgaard M; Overgaard J
Radiother Oncol; 2003 Nov; 69(2):127-35. PubMed ID: 14643949
[TBL] [Abstract][Full Text] [Related]
16. Searching for genetic determinants of normal tissue radiosensitivity--are we on the right track?
Andreassen CN
Radiother Oncol; 2010 Oct; 97(1):1-8. PubMed ID: 20817285
[No Abstract] [Full Text] [Related]
17. The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes.
Giotopoulos G; Symonds RP; Foweraker K; Griffin M; Peat I; Osman A; Plumb M
Br J Cancer; 2007 Mar; 96(6):1001-7. PubMed ID: 17325707
[TBL] [Abstract][Full Text] [Related]
18. Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients.
Quarmby S; Fakhoury H; Levine E; Barber J; Wylie J; Hajeer AH; West C; Stewart A; Magee B; Kumar S
Int J Radiat Biol; 2003 Feb; 79(2):137-43. PubMed ID: 12569017
[TBL] [Abstract][Full Text] [Related]
19. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM--a study based on DNA from formalin fixed paraffin embedded tissue samples.
Andreassen CN; Alsner J; Overgaard M; Sørensen FB; Overgaard J
Int J Radiat Biol; 2006 Aug; 82(8):577-86. PubMed ID: 16966185
[TBL] [Abstract][Full Text] [Related]
20. Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity.
Dorling L; Barnett GC; Michailidou K; Coles CE; Burnet NG; Yarnold J; Elliott RM; Dunning AM; Pharoah PD; West CM
Clin Cancer Res; 2016 Mar; 22(6):1413-20. PubMed ID: 26510858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
